BBY
42
2
SIG
50
-5
GWW
76
2
MUR
42
-2
TSCO
48
-3
HUM
41
-2
AMGN
31
-16
O
24
2
AVGO
27
2
XRX
42
-3
SJM
45
9
SWK
67
-4
AVY
54
-4
HCP
62
-8
RIG
55
-6
LEN
57
-4
HOG
36
-3
PSX
50
3
MRK
35
2
FCX
57
-2
BBY
42
2
SIG
50
-5
GWW
76
2
MUR
42
-2
TSCO
48
-3
HUM
41
-2
AMGN
31
-16
O
24
2
AVGO
27
2
XRX
42
-3
SJM
45
9
SWK
67
-4
AVY
54
-4
HCP
62
-8
RIG
55
-6
LEN
57
-4
HOG
36
-3
PSX
50
3
MRK
35
2
FCX
57
-2
Financhill
Back

Black Diamond Therapeutics 10K Form

Sell
27

BDTX
Black Diamond Therapeutics

Last Price:
2.57
Seasonality Move:
28.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDTX News And Ratings

See the #1 stock for the next 7 days that we like better than BDTX

BDTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-11.32M
Price / Cash Flow: 0
Annual Sales: $1.72
Price / Book: 1.43

Profitability

EPS (TTM): -1.33000
Net Income (TTM): $-73.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Black Diamond Therapeutics Earnings Forecast

Key Black Diamond Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Black Diamond Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDTX
CUSIP: 09203E
Website: blackdiamondtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDTX Technical Analysis vs Fundamental Analysis

Sell
27
Black Diamond Therapeutics (BDTX) is a Sell

Is Black Diamond Therapeutics a Buy or a Sell?